Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759623 | SCV000889064 | uncertain significance | not provided | 2017-09-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002298757 | SCV002591786 | uncertain significance | Hereditary breast ovarian cancer syndrome | 2023-02-01 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 619811). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt BRCA2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with BRCA2-related conditions. This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 1795 of the BRCA2 protein (p.Lys1795Arg). This variant is not present in population databases (gnomAD no frequency). |
University of Washington Department of Laboratory Medicine, |
RCV003158109 | SCV003847207 | likely benign | Hereditary cancer-predisposing syndrome | 2023-03-23 | criteria provided, single submitter | curation | Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673). |